Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

45.09 +2.15 (+5.01%)
Streaming Delayed Price Updated: 9:45 AM EST, Dec 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,056,320
Open 43.52
Bid (Size) 44.98 (1)
Ask (Size) 45.19 (1)
Prev. Close 42.94
Today's Range 43.16 - 45.38
52wk Range 35.80 - 170.47
Shares Outstanding 385,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is Now the Time to Buy 3 of the S&P 500's Worst-Performing Stocks of 2024?
Via The Motley Fool
Topics Stocks
Exposures US Equities
Rivian Automotive, Rocket Lab And Moderna Are Among Top 10 Large-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?
Top performers last week: RIVN, RKLB, SRPT, EXAS, ESTC, ULTA, MRNA, RL, CPRT, SNAP. Any in your portfolio? Citigroup raises price target on ULTA and SNAP. 
Via Benzinga

Performance

YTD
-59.92%
-59.92%
1 Month
-15.39%
-15.39%
3 Month
-38.60%
-38.60%
6 Month
-70.85%
-70.85%
1 Year
-44.06%
-44.06%

More News

Read More
10 Worst Performing Large-Caps Last 12 Months
Via Talk Markets
Topics Stocks / Equities
Bird Flu Found In Raw Milk Leads To Recall In California
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Here's How Much $100 Invested In Moderna 5 Years Ago Would Be Worth Today
Via Benzinga
Moderna to Present at Upcoming Conferences in December 2024
Via ACCESSWIRE
Looking Into Moderna's Recent Short Interest
Via Benzinga
Unpacking the Latest Options Trading Trends in Moderna
Via Benzinga
These Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over
Via The Motley Fool
BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday
Via Benzinga
Large-Cap Stocks In Trouble - Saturday, Nov. 23
Via Talk Markets
Topics Stocks / Equities
Is Biotech’s Bull Run Over? Examining Election Impacts
Via MarketBeat
Topics ETFs Government
Exposures Political
Demystifying Moderna: Insights From 16 Analyst Reviews
Via Benzinga
Mutated Bird Flu Case In California Puts Humans At Increased Risk, So Which Companies Are Developing Vaccines?
Via Benzinga
Moderna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS Nomination
Via Benzinga
Tech, Tesla Helping Wall Street Higher
Via Talk Markets
Topics Stocks / Equities
Dow Tumbles Over 300 Points Following Economic Reports, Nvidia, Microsoft Decline: Fear & Greed Index Moves To 'Neutral' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
Large-Cap Stocks In Trouble - Sunday, Nov. 17
Via Talk Markets
Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers
Via Benzinga
Deciphering Disruption: Inside Cathie Wood's Latest Plays
Via MarketBeat
Topics Artificial Intelligence ETFs
Exposures Artificial Intelligence
Moderna Shares Are Dipping Today: What's Going On?
Via Benzinga
Topics Government
Exposures Political
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
Via Benzinga
European And US Vaccine Stocks Are Under Pressure - Here's WHy
Via Benzinga
Exposures Product Safety
Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS
Via Investor's Business Daily
Topics Government
Exposures Political
WHO Calls Vaccines 'Absolutely Critical' As Trump's Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill
Via Benzinga
Topics Government
Exposures Political
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.